K-numberK242166
Device nameTribusConnect
ApplicantTribusmed Beheer BV
Product codeQIH
Device classClass II
Decision dateMar 31, 2025
DecisionSubstantially Equivalent
Regulation892.2050
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

TribusConnect is a cloud-based medical image management and processing software that allows healthcare professionals to securely access, review, manipulate, measure, and visualize CT images in DICOM format from remote locations. It is designed for pre-procedural planning and post-procedural analysis of cardiac interventions in adult patients (22 years and older), using machine learning-based heart segmentation and left atrial appendage localization to support clinical decision-making.

Technological characteristics

TribusConnect is a web-based cloud application supporting multiple platforms (Windows, Mac, iOS, Android) that processes CT DICOM data server-side to produce 2D, 3D, 4D, MPR, MIP, and volume renderings with ML-based segmentation of seven heart structures. It provides manual measurement tools (distance, area, angle, signal intensity) accurate within 5% and semi-automated LAA localization. Unlike the primary predicate (RemotEye Viewer), it supports only CT modality; unlike the secondary predicate (TruPlan), it segments more cardiac structures and uses the LAA tool as navigation rather than measurement initiation.

Test standards cited

IEC 62304:2015 (medical device software lifecycle), ISO 14971:2019 (risk management), NEMA 3.1–3.20 (2016) DICOM standard, FDA guidance on Device Software Functions, Cybersecurity in Medical Devices, and Technical Performance Assessment of Quantitative Imaging.

Substantial equivalence argument

TribusConnect is substantially equivalent because it shares the same intended use (web-based remote viewing and measurement of DICOM images for cardiac intervention planning) and core technological functions with both predicates. Performance validation showed heart segmentation achieved 100% correct bone removal and 100% clinically usable rendered views; LAA localization achieved 97% accuracy within 10mm of the predicate device's landing zone. Manual measurement validation via phantom studies met the 5% accuracy criterion. The differences in supported modalities (CT only vs. multi-modality), number of segmented structures (seven vs. four), and LAA tool use (navigation vs. measurement initiation) do not introduce new safety or performance risks, as confirmed by verification and validation testing and cybersecurity assessment.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →